0001415889-24-007093.txt : 20240306
0001415889-24-007093.hdr.sgml : 20240306
20240306175725
ACCESSION NUMBER: 0001415889-24-007093
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240305
FILED AS OF DATE: 20240306
DATE AS OF CHANGE: 20240306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ZASLOFF MICHAEL A
CENTRAL INDEX KEY: 0001033511
ORGANIZATION NAME:
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36509
FILM NUMBER: 24727364
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001297184
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 330702205
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
BUSINESS PHONE: 909-980-9484
MAIL ADDRESS:
STREET 1: 11570 SIXTH STREET
CITY: RANCHO CUCAMONGA
STATE: CA
ZIP: 91730
4
1
form4-03062024_100318.xml
X0508
4
2024-03-05
0001297184
Amphastar Pharmaceuticals, Inc.
AMPH
0001033511
ZASLOFF MICHAEL A
C/O AMPHASTAR PHARMACEUTICALS, INC.
11570 6TH STREET
RANCHO CUCAMONGA
CA
91730
true
false
false
false
0
Common Stock
2024-03-05
4
S
0
9389
47.0626
D
24437
D
Common Stock
2024-03-05
4
S
0
3111
47.526
D
21326
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.435 to $47.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.435 to $47.68, inclusive.
/s/ Eva Wen, by power of attorney
2024-03-06